Patents by Inventor Marc MARESCA

Marc MARESCA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIMICROBIAL PEPTIDES, VARIANTS AND CHEMICAL ANALOGUES THEREOF AND THEIR USES
    Publication number: 20250051403
    Abstract: The present invention relates to antimicrobial peptides, variants and chemical analogues thereof; in particular, a peptide of 20 amino acids, named Michelicin, having the sequence RVCVRICRNGRCYRRCWNT, derived from a longer precursor with a BRICHOS domain from the marine worm Capitella. The peptide has several cysteines which form disulfide bridges and provide stability in salt conditions. Several derivatives and analogues were produced. The peptide and the derivatives show antimicrobial activity against a wide range of bacteria. The application also concerns nucleic acid sequences encoding these, pharmaceutical composition and to their use as a drug, preservative and disinfectant.
    Type: Application
    Filed: December 16, 2022
    Publication date: February 13, 2025
    Applicants: UNIVERSITE DE LILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE D'AIX MARSEILLE, SORBONNE UNIVERSITE, ECOLE CENTRALE DE MARSEILLE
    Inventors: Aurélie TASIEMSKI, Céline WICHLACZ, Marc MARESCA, Stéphane CANAAN, Jean-François CAVALIER, Kamel MABROUK, Stéphane HOURDEZ
  • AURONE DERIVATIVES AND USES THEREOF FOR CONTROLLING BACTERIA AND/OR FUNGI
    Publication number: 20230295103
    Abstract: The present invention relates to aurones compounds of formula (I) and their uses for controlling a bacterium and/or a fungus. The invention also relates to the use of such compounds as phytoprotective and/or decontaminating and/or disinfectant agent and compositions comprising them.
    Type: Application
    Filed: July 8, 2021
    Publication date: September 21, 2023
    Inventors: MAXIME ROBIN, MARC MARESCA, HAMZA OLLEIK, VALÉRIE PIQUE, JOSETTE PERRIER-VIRET, JEAN-MICHEL BOLLA, FABIENNE NEULAT-RIPOLL
  • Use of fungal cyclic peptides of the destruxin type as antibacterial agents active against Clostridium perfringens
    Publication number: 20220133842
    Abstract: The present invention relates to the use of a destruxin or derivatives thereof to prevent or control Clostridium perfringens, in human or veterinary therapy, or in animal nutrition.
    Type: Application
    Filed: February 25, 2020
    Publication date: May 5, 2022
    Inventors: Marc MARESCA, Josette PERRIER, Cendrine NICOLETTI, Sybille TACHON, Clarisse ROBLIN, Michael LAFOND, Hamza OLLEIK, Michel FONS